Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic Mechanisms

Leber, A; Hontecillas, R; Zoccoli-Rodriguez, V; Bassaganya-Riera, J

Bassaganya-Riera, J (reprint author), Landon Biopharma Inc, 1800 Kraft Dr,Suite 216, Blacksburg, VA 24060 USA.

INFLAMMATORY BOWEL DISEASES, 2018; 24 (9): 1978

Abstract

Background: Inflammatory bowel disease (IBD) afflicts 5 million people and is increasing in prevalence. There is an unmet clinical need for safer and ......

Full Text Link